New Key Statistics Module, Z-Score and F-Score
NAS:FATE Key Ratios
Market Cap $ M | 432.38 |
Enterprise Value $ M | 228.70 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.02 |
Price/Sales | 5.98 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 63.00 |
EPS (TTM) $ | -1.64 |
Beneish M-Score | -4.16 |
10-y EBITDA Growth Rate % | -3.70 |
5-y EBITDA Growth Rate % | -15.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.20 |
EV-to-EBITDA | -1.33 |
PEG | -- |
Shares Outstanding M | 113.78 |
Net Margin (%) | -253.30 |
Operating Margin % | -299.86 |
Pre-tax Margin (%) | -253.30 |
Quick Ratio | 8.48 |
Current Ratio | 8.48 |
ROA % (ttm) | -27.09 |
ROE % (ttm) | -37.07 |
ROIC % (ttm) | -93.06 |
Dividend Yield % | -- |
Altman Z-Score | -1.66 |
FATE Number of Guru Trades
FATE Volume of Guru Trades
Gurus Latest Trades with NAS:FATE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FATE is held by these investors
Total 1
Fate Therapeutics Inc Insider Transactions
No Available Data
News about NAS:FATE
Total 0- 1